Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Raw Materials (2025)

Historic Raw Materials for Outlook Therapeutics (OTLK) over the last 1 years, with Q4 2025 value amounting to $2.4 million.

  • Outlook Therapeutics' Raw Materials changed N/A to $2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2025, which is N/A changed from last year.
  • Outlook Therapeutics' Raw Materials amounted to $2.4 million in Q4 2025.
  • Outlook Therapeutics' 5-year Raw Materials high stood at $2.4 million for Q3 2025, and its period low was $2.4 million during Q3 2025.